Skip to main content
SpringerLink
Log in

Efficacy of immunotherapy, gut microbiota and impact of antibiotic use: are there confounding factors?

  • Letter to the Editor
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gopalakrishnan V et al (2018) The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell 33:570–580

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Cremonesi E, Governa V, Garzon JFG et al (2018) Gut microbiota modulate T cell trafficking into human colorectal cancer. Gut 67:1984–1994

    Article  CAS  PubMed  Google Scholar 

  3. Routy B, Le Chatelier E, Derosa L et al (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359:91–97

    Article  CAS  Google Scholar 

  4. Derosa L, Hellmann MD, Spaziano M (2018) Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer. Ann Oncol 29:1437–1444

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Keiser RJ, Huitema ADR, Schellens JMH, Beijnen JH (2010) Clinical pharmacokinetics of therapeutic monoclonal antibodies. Clin Pharmacokinet 49:493–507

    Article  Google Scholar 

  6. Ternant D, Azzopardi N, Raoul W et al (2018) Influence of antigen mass on the pharmacokinetics of therapeutic antibodies in humans. Clin Pharmacokinet 58(2):169–187. https://doi.org/10.1007/s40262-018-0680-3

    Article  CAS  Google Scholar 

  7. Feng Y, Wang X, Bajaj C et al (2017) Nivolumab exposure-response analyses of efficacy and safety in previously treated squamous or non-squamous non-small cell lung cancer. Clin Cancer Res 23:5394–5405

    Article  CAS  PubMed  Google Scholar 

  8. Nenu I, Gafencu GA, Popescu T, Kacso G (2017) Lactate—a new frontier in the immunology and therapy of prostate cancer. J Cancer Res Ther 13:406–411

    PubMed  Google Scholar 

  9. Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL (2019) Separating host and microbiome contributions to drug pharmacokinetics and toxicity. Science 363:1. https://doi.org/10.1126/science.aat9931

    Article  CAS  Google Scholar 

  10. Casanovas Blanco M (2018) Critical review of emergency department management of chemotherapy complications in cancer patients. Eur J Cancer Care 28(2):e12974. https://doi.org/10.1111/ecc.12974

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oncopharmacology Unit, Centre Antoine Lacassagne and EA 3836 Nice University, 33 avenue de Valombrose, 06189, Nice Cedex 2, France

    G. Milano

Authors
  1. G. Milano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Milano.

Ethics declarations

Conflict of interest

The author declares no conflict of interest.

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Milano, G. Efficacy of immunotherapy, gut microbiota and impact of antibiotic use: are there confounding factors?. Cancer Chemother Pharmacol 84, 223–224 (2019). https://doi.org/10.1007/s00280-019-03833-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-019-03833-2

Search

Navigation